These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20357314)

  • 1. Antipsychotics and borderline personality disorder.
    Adil J
    Br J Psychiatry; 2010 Apr; 196(4):332; author reply 332. PubMed ID: 20357314
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for borderline personality disorder: NICE guideline.
    Kendall T; Burbeck R; Bateman A
    Br J Psychiatry; 2010 Feb; 196(2):158-9. PubMed ID: 20118465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders.
    Zarate CA; Vemuri M; Cavanagh S; Land M
    Curr Psychiatry Rep; 2000 Aug; 2(4):291-7. PubMed ID: 11122971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trials for Treatment of Borderline Personality Disorder.
    Schulz SC; Black DW
    Am J Psychiatry; 2015 Aug; 172(8):793. PubMed ID: 26234601
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
    Ingenhoven TJ; Duivenvoorden HJ
    J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
    Grootens KP; Verkes RJ
    Pharmacopsychiatry; 2005 Jan; 38(1):20-3. PubMed ID: 15706462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological treatment of borderline personality disorder].
    Mazaira S
    Vertex; 2004 Dec-2005 Feb; 15(58):303-8. PubMed ID: 15597127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute movement disorders associated with the use of second-generation antipsychotics in borderline personality disorder: a meta-analysis.
    Willems AE; Tenback DE; Ingenhoven TJ; van Harten PN
    J Clin Psychopharmacol; 2014 Aug; 34(4):520-2. PubMed ID: 24911435
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone in comorbid borderline personality disorder and dysthymia.
    Szigethy EM; Schulz SC
    J Clin Psychopharmacol; 1997 Aug; 17(4):326-7. PubMed ID: 9241018
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy in borderline patients.
    Cole JO; Salomon M; Gunderson J; Sunderland P; Simmonds P
    Compr Psychiatry; 1984; 25(3):249-54. PubMed ID: 6145541
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article.
    Rosenberg R
    Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for the Management of Suicidal Behavior in Borderline Personality Disorder Complicated by a Cancer Diagnosis: A Case Report and Review of the Literature.
    OʼLeary J; Purcell A; Hynes C; Huet J; Romanos M; McWilliams S
    J Clin Psychopharmacol; 2018 Dec; 38(6):642-644. PubMed ID: 30334867
    [No Abstract]   [Full Text] [Related]  

  • 20. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.